Advertisement

Zika Debate In Congress

04:47
Download Audio
Resume
Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAD), speaks with Dr. Sylvain Aldighieri, Zika Incident Manager for the Pan American Health Organization (PAHO), during a media briefing concerning the Zika virus, at the Pan American Health Organization headquarters, May 3, 2016, in Washington, DC. (Drew Angerer/Getty Images)
Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAD), speaks with Dr. Sylvain Aldighieri, Zika Incident Manager for the Pan American Health Organization (PAHO), during a media briefing concerning the Zika virus, at the Pan American Health Organization headquarters, May 3, 2016, in Washington, DC. (Drew Angerer/Getty Images)

After several months of back and forth between the White House and Congress, the Senate will vote today on Zika funding. A $1.1 billion bipartisan compromise is likely to get Senate approval. The Obama Administration had asked for more money. What does a delay in funding mean for research? And where is the US on developing a vaccine? Here and Now's Robin Young speak with Alison Kodjak, health policy correspondent for NPR.

Guest

This segment aired on May 17, 2016.

Advertisement

More from Here & Now

Listen Live
Close